Incepta Pharmaceuticals
Introduction
Incepta Pharmaceuticals Ltd., founded in 1999 and headquartered in Dhaka, Bangladesh, is one of the leading pharmaceutical companies in the country. Known for its commitment to quality, innovation, and accessibility, Incepta has become a trusted name in the global pharmaceutical landscape.
The company focuses on producing a wide range of high-quality and affordable medicines, serving both local and international markets.
Therapeutic Specializations
Incepta Pharmaceuticals specializes in the production of diverse medicines across key therapeutic categories:
- Oncology (Cancer Treatment)
- Vaccines
- Diabetes Management
- Cardiovascular Health
- Gastrointestinal Care
- Neurology and Psychiatry
- Respiratory Care
- Anti-Infective and Antiviral Medicines
Global Reach
Incepta Pharmaceuticals exports its products to over 80 countries, showcasing its strong global presence:
- Asia: Active in markets like India, Nepal, Sri Lanka, and Malaysia.
- Africa: Incepta provides affordable medicines for critical diseases in countries such as Kenya, Nigeria, and South Africa.
- Middle East: The company has a significant footprint in the Gulf Cooperation Council (GCC) countries, supplying advanced formulations.
- Europe and North America: Incepta is making inroads into highly regulated markets, emphasizing quality and innovation.
- Latin America: Expanding its reach with cost-effective generics and specialty medicines.
Research and Development (R&D)
Incepta invests significantly in R&D to develop advanced drug delivery systems, biosimilars, and niche generics.
The company focuses on developing affordable alternatives to high-cost medications, ensuring that patients worldwide have access to life-saving treatments.
Manufacturing Excellence
Incepta operates state-of-the-art manufacturing facilities accredited by global regulatory bodies such as the US FDA, WHO, and EMA.
These facilities enable the production of a wide range of formulations, including tablets, capsules, injections, inhalers, and biologics.
Social Responsibility
Incepta is dedicated to improving community health through its corporate social responsibility (CSR) programs. The company actively engages in initiatives for healthcare access, education, and disaster relief, aligning its business goals with societal needs.
Key Products
- Vaccines: Influenza vaccine, Hepatitis B vaccine, COVID-19 vaccine.
- Oral Hypoglycemics: Metformin, Glimepiride combinations.
- Oncology Drugs: Imatinib, Erlotinib, and generic chemotherapy agents.
- Respiratory Solutions: Asthma inhalers, nebulizers, and COPD treatments.
- Antiviral Drugs: Remdesivir, Favipiravir for COVID-19 treatment.
